Xolpride 50 Tablet contains Amisulpride 50mg, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and other psychotic disorders. Amisulpride acts selectively on dopamine D2 and D3 receptors, exhibiting both antipsychotic and antidepressant properties depending on the dosage. At low doses, it preferentially blocks presynaptic dopamine autoreceptors, enhancing dopaminergic transmission, which may alleviate negative symptoms and depressive features. At higher doses, it antagonizes postsynaptic receptors, reducing positive symptoms such as hallucinations and delusions. Xolpride 50 is effective in managing acute and chronic phases of schizophrenia, improving cognitive function and social engagement. The medication is generally well-tolerated, with side effects including extrapyramidal symptoms, hyperprolactinemia, weight gain, and sedation. It should be used with caution in patients with a history of cardiac arrhythmias, seizures, or renal impairment. Regular monitoring of blood glucose, lipid profile, and prolactin levels is recommended during prolonged therapy. Dose adjustments may be necessary based on clinical response and tolerability. Xolpride 50 Tablet should be administered under strict medical supervision, adhering to prescribed guidelines to optimize therapeutic outcomes and minimize adverse effects. It is contraindicated in patients with hypersensitivity to Amisulpride or related compounds.